NLS Pharmaceutics Ltd. Ordinary Shares (NLSP)
NLS Pharmaceutics Ltd. is a biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders. The company works on enhancing drug delivery and improving treatment options for conditions such as schizophrenia, depression, and other neurological illnesses. Its pipeline includes formulations aimed at addressing unmet medical needs in the CNS therapeutic space.
Company News
NLS Pharmaceutics and Kadimastem have been granted a Hong Kong patent for cell-selection technology used in IsletRx, a stem cell-derived therapy for insulin-dependent diabetes, expanding their intellectual property protection in Asia.
Read this before investing in penny stocks The post Investing in Penny Stocks With $1k, What to Know appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.